高级检索
    刘婉明, 王婷婷, 张涅, 章龙珍. 局晚期食管鳞癌同步放化疗后复发预测模型的构建和验证[J]. 徐州医科大学学报, 2022, 42(12): 889-895. DOI: 10.3969/j.issn.2096-3882.2022.12.006
    引用本文: 刘婉明, 王婷婷, 张涅, 章龙珍. 局晚期食管鳞癌同步放化疗后复发预测模型的构建和验证[J]. 徐州医科大学学报, 2022, 42(12): 889-895. DOI: 10.3969/j.issn.2096-3882.2022.12.006
    Construction and validation of a predictive model for recurrence after simultaneous radiotherapy for locally advanced squamous esophageal cancer[J]. Journal of Xuzhou Medical University, 2022, 42(12): 889-895. DOI: 10.3969/j.issn.2096-3882.2022.12.006
    Citation: Construction and validation of a predictive model for recurrence after simultaneous radiotherapy for locally advanced squamous esophageal cancer[J]. Journal of Xuzhou Medical University, 2022, 42(12): 889-895. DOI: 10.3969/j.issn.2096-3882.2022.12.006

    局晚期食管鳞癌同步放化疗后复发预测模型的构建和验证

    Construction and validation of a predictive model for recurrence after simultaneous radiotherapy for locally advanced squamous esophageal cancer

    • 摘要: 目的 讨论影响局晚期食管鳞癌同步放化疗后3年内复发的危险因素,构建复发预测风险模型并验证。方法 回顾性分析2017年6月-2019年6月首次就诊于徐州医科大学附属医院放疗科的156例局晚期食管鳞癌患者的相关资料。按7:3的比例随机将156例患者分为训练集(109例)和测试集(47例),在训练集中统计并分析3年内复发的危险因素,使用列线图构建预测模型,应用校准曲线和临床决策曲线在训练集和测试集中对模型的预测效能进行验证。结果 156例患者中,87例患者在3年内经组织学或影像学证实复发,复发率为55.77%,单因素及多因素分析结果显示,SII≥643.8、PNI<48.05、有淋巴结转移、分化不良是局晚期食管鳞癌同步放化疗后3年内复发的独立危险因素(p<0.05),以上风险因素纳入模型。校准曲线显示预测与实际情况具有较好的拟合度,临床决策曲线则提示大部分患者都能受到临床获益。结论 本研究首次讨论了SII、PNI、FAR对食管癌同步放化疗后3年内复发的影响,可为临床医生综合评估病情,为患者制定个体化随访监测方案提供参考依据。

       

      Abstract: ob<x>jective To discuss the risk factors affecting recurrence within 3 years after synchronous radiotherapy for focal advanced esophageal squamous carcinoma, and construct a recurrence prediction risk model and validate it. Methods The data related to 156 patients with focal advanced esophageal squamous carcinoma who first visited the radiotherapy department of the Affiliated Hospital of Xuzhou Medical University from June 2017 to June 2019 were retrospectively analyzed. The 156 patients were randomly divided into training cohort (109 patients) and test ing cohort (47 patients) in the ratio of 7:3. Risk factors for recurrence within 3 years were counted and analyzed in the training cohort, prediction models were constructed using column line plots, and the predictive efficacy of the models was validated by applying calibration curves and clinical decision curves in the training and testing cohorts.Results Among 156 patients, 87 patients had histologically or imaging confirmed recurrence within 3 years, with a recurrence rate of 55.77%. The results of univariate and multifactorial analyses showed that SII ≥ 643.8, PNI < 48.05, presence of lymph node me<x>tastasis, and poor differentiation were independent risk factors for recurrence within 3 years after synchronous radiotherapy for locally advanced squamous esophageal cancer (p<0.05), and the above risk factors were included in the model. The calibration curve showed a good fit between prediction and reality, and the clinical decision curve suggested that most patients were clinically benefited.Conclusion This study is the first to discuss the effects of SII, PNI, and FAR on recurrence within 3 years after simultaneous radiotherapy for esophageal cancer, which can provide a reference basis for clinicians to comprehensively assess the disease and develop individualized follow-up monitoring programs for patients

       

    /

    返回文章
    返回